Effect of Topical Nepafenac in Macular Thickening Related to Pan-Retinal Photocoagulation

• Status: Unknown status
• Trial end date: 2009-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether topical nepafenac (qid) is effective in preventing and treating macular thickening related pan-retinal photocoagulation in patients with diabetic retinopathy.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Asociación para Evitar la Ceguera en México
• Treatments: Nepafenac

Criteria

Inclusion Criteria:

• Patients with Severe and proliferative Diabetic Retinopathy

• Symmetric severity grade on both eyes

• Best corrected visual acuity better than 20/80

Exclusion Criteria:

• Clinical significant macular edema

• Lens opacity

• Ocular surgery 6 months or less before recruit

• Uveitis history

• Actual use of topical or systemic non-steroidal anti inflammatory agents

• Actual or history of other macular diseases

• Ocular surface diseases

• Vitreomacular traction syndrome

• Other vascular retinal diseases different to diabetic retinopathy

• Actual or history of use of topical prostaglandin analogues